Akero Therapeutics’s $220 Million Registered Direct Offering

Pietro Martinoia North America Legal Chronicle
Tagged:

Goodwin advised Akero Therapeutics on the offering, and Cooley advised the underwriter involved.Akero Therapeutics (Nasdaq: AKRO) announced the closing of its underwritten registered direct offering of…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Pietro Martinoia

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here